<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00940654</url>
  </required_header>
  <id_info>
    <org_study_id>JSICM&amp;KSCCM FACE</org_study_id>
    <nct_id>NCT00940654</nct_id>
  </id_info>
  <brief_title>The Fever and Antipyretic in Critically Illness Evaluation Study</brief_title>
  <acronym>FACE</acronym>
  <official_title>The Fever and Antipyretic in Critically Illness Evaluation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Japanese Society of Intensive Care Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Japanese Society of Intensive Care Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multination multicenter observational study is to determine the impact of
      fever and antipyretic on outcomes in critically ill patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fever is common in critically ill patients.Antipyretic therapy for fever is routinely
      performed in intensive care.There are studies to assess the relationship between fever and
      mortality in non-neurological ICU. However, all of them did not have any information of
      antipyretic therapy. There are two small, single center RCT, which suggested a potential risk
      for antipyretic therapy. Thus, a large RCT might be ethically difficult.

      It is unfortunate that there is not enough information on how the investigators should
      control body temperature in non-neurological critically ill patients, because fever is a very
      common physiological abnormality in this cohort. From the beginning, it would, therefore, be
      desirable to understand several aspects of fever and antipyretic therapy in ICU patients, as
      1)How often fever occurs in our ICUs, 2)To what degree fever is independently associated with
      mortality?, 3)How often antipyretic therapy is prescribed?, 4)How effectively antipyretic can
      decrease temperature?, 5)How different is lowering temperature with medications compared with
      cooling?, 6)To what degree antipyretic is independently associated with mortality?

      Thus, the investigators plan to address these questions by conducting a multi-national
      multi-center prospective observational trial, named &quot;The Fever and Antipyretic in Critically
      illness evaluation study&quot; (The FACE study)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>28 days mortality</measure>
    <time_frame>28days after ICU admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICU free days at 28 days</measure>
    <time_frame>28 days after ICU admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital free days at 28 days</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator free days at 28 days</measure>
    <time_frame>28 days at ICU admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal replacement therapy free days at 28 days</measure>
    <time_frame>28 days at ICU admission</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1426</enrollment>
  <condition>Fever</condition>
  <condition>Hyperthermia</condition>
  <arm_group>
    <arm_group_label>Patients with fever</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without any fever</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Antipyretic therapy</intervention_name>
    <description>External cooling;Internal cooling;Non steroid anti inflammatory drugs; Acetaminophen; Steroid</description>
    <arm_group_label>Patients with fever</arm_group_label>
    <other_name>External cooling</other_name>
    <other_name>Internal cooling</other_name>
    <other_name>Non steroid anti inflammatory drugs</other_name>
    <other_name>Acetaminophen</other_name>
    <other_name>Steroid</other_name>
    <other_name>Others</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult non-neurological critically ill patients required intensive care for more than 48
        hour.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult non-neurological critically ill patients (20 years old or older).

          -  ICU patients expected to require intensive care for more than 48 hour.

        Exclusion Criteria:

          -  Patients with brain injury (suspected or proven)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Younsuck Koh, M.D. PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Korean Society of Critical Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Masaji Nishimura, M.D. PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Japanese Society of Intensive Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jae Yeol Kim, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korean Society of Critical Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gee Young Suh, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korean Society of Critical Care Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moritoki Egi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Japanese Society of Intensive Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Japanese Society of Intensive Care Medicine</name>
      <address>
        <city>Bunkyo-ku</city>
        <state>Tokyo</state>
        <zip>113-0033</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korean Society of Critical Care Medicine</name>
      <address>
        <city>Songpa-gu</city>
        <state>Seoul</state>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
    <country>Korea, Republic of</country>
  </location_countries>
  <link>
    <url>http://www.jsicm.org/en/</url>
    <description>JSICM</description>
  </link>
  <verification_date>September 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2009</study_first_submitted>
  <study_first_submitted_qc>July 15, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 16, 2009</study_first_posted>
  <last_update_submitted>May 18, 2010</last_update_submitted>
  <last_update_submitted_qc>May 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Japanese Society of Intensive Care Medicine</name_title>
    <organization>Japanese Society of Intensive Care Medicine</organization>
  </responsible_party>
  <keyword>Fever</keyword>
  <keyword>Antipyretic</keyword>
  <keyword>Infection</keyword>
  <keyword>Mortality</keyword>
  <keyword>Cooling</keyword>
  <keyword>Non steroid anti inflammatory drugs</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Steroid</keyword>
  <keyword>ICU</keyword>
  <keyword>Intensive care</keyword>
  <keyword>Critically ill</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fever</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Antipyretics</mesh_term>
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

